WEST JEFFERSON, OHIO / ACCESS Newswire / January 30, 2025 / AmplifyBio, a leading preclinical CRO and CDMO played a pivotal ...
VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback